Applications are now open for the 2021 Program. Deadline is June 30, 2021. View the slides from our April 2021 webinar to learn more

Crystal Icenhour

Aperiomics, Inc.

Describe your industry experience:
Crystal R Icenhour, PhD has over 15 years of research and development experience in fields such as mycology, infectious diseases, molecular biology, molecular diagnostics, and bioinformatics.  She has lead both for-profit and not-for-profit organizations in early stage biotechnology spaces.  Dr. Icenhour has co-founded two biotechnology companies, authored numerous scientific publications, been issued two patents, received millions in small business grant funding, raised angel investor capital, and exited her first company through acquisition in 2013.  She has deep knowledge in research, development, and operations of molecular diagnostic, infectious disease, and transformative technologies.

Describe your functional experience:
Dr. Icenhour is an expert in early stage biotechnology companies.  She has broad experience in all functions of biotechnology companies, including founding, research, development, manufacturing, operations, sales, marketing, strategic partner relations, finance, investor relations, and acquisition.

Describe your key business transactional experience:
Dr. Icenhour has raised $1.2 million in angel capital from high net-worth individuals to date.  Additionally, she led acquisition efforts for her first company when approached with an unsolicited bid.

What is the most important skill you bring to a corporate board?
Dr. Icenhour has an intimate understanding of early stage research, development, manufacturing, operations, sales, marketing, finance, capital, and acquisition.  In particular, she has worked in high stress, complex environments and is skilled at conflict resolution and ensuring all parties feel valued.  She is an innovator, an entrepreneur, a leader.